Information Journal Paper
APA:
Copy. (2018). Effectiveness of delayed-release dimethyl fumarate on clinical and patient-reported outcomes in patients with relapsing multiple sclerosis switching from glatiramer acetate: RESPOND, a prospective observational study. CLINICAL THERAPY, 40(12), 2077-2087. SID. https://sid.ir/paper/757794/en
Vancouver:
Copy. Effectiveness of delayed-release dimethyl fumarate on clinical and patient-reported outcomes in patients with relapsing multiple sclerosis switching from glatiramer acetate: RESPOND, a prospective observational study. CLINICAL THERAPY[Internet]. 2018;40(12):2077-2087. Available from: https://sid.ir/paper/757794/en
IEEE:
Copy, “Effectiveness of delayed-release dimethyl fumarate on clinical and patient-reported outcomes in patients with relapsing multiple sclerosis switching from glatiramer acetate: RESPOND, a prospective observational study,” CLINICAL THERAPY, vol. 40, no. 12, pp. 2077–2087, 2018, [Online]. Available: https://sid.ir/paper/757794/en